Literature DB >> 26025911

Initiation of the ATM-Chk2 DNA damage response through the base excision repair pathway.

Wen-Cheng Chou1, Ling-Yueh Hu1, Chia-Ni Hsiung1, Chen-Yang Shen2.   

Abstract

The DNA damage response (DDR) is activated by various genotoxic stresses. Base lesions, which are structurally simple and predominantly fixed by base excision repair (BER), can trigger the ataxia telangiectasia mutated (ATM)-checkpoint kinase 2 (Chk2) pathway, a DDR component. How these lesions trigger DDR remains unclear. Here we show that, for alkylation damage, methylpurine-DNA glycosylase (MPG) and apurinic/apyrimidinic endonuclease 1, both of which function early in BER, are required for ATM-Chk2-dependent DDR. In addition, other DNA glycosylases, including uracil-DNA glycosylase and 8-oxoguanine glycosylase, which are involved in repairing deaminated bases and oxidative damage, also induced DDR. The early steps of BER therefore play a vital role in modulating the ATM-Chk2 DDR in response to base lesions, facilitating downstream BER processing for repair, in which the formation of a single-strand break was shown to play a critical role. Moreover, MPG knockdown rescued cell lethality, its overexpression led to cell death triggered by DNA damage and, more interestingly, higher MPG expression in breast and ovarian cancers corresponded with a greater probability of relapse-free survival after chemotherapy, underscoring the importance of glycosylase-dependent DDR. This study highlights the crosstalk between BER and DDR that contributes to maintaining genomic integrity and may have clinical applications in cancer therapy.
© The Author 2015. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26025911     DOI: 10.1093/carcin/bgv079

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  14 in total

Review 1.  Oxidative stress and DNA damage after cerebral ischemia: Potential therapeutic targets to repair the genome and improve stroke recovery.

Authors:  Peiying Li; R Anne Stetler; Rehana K Leak; Yejie Shi; Yan Li; Weifeng Yu; Michael V L Bennett; Jun Chen
Journal:  Neuropharmacology       Date:  2017-11-08       Impact factor: 5.250

2.  Oxidative stress-induced CREB upregulation promotes DNA damage repair prior to neuronal cell death protection.

Authors:  Nicolás Pregi; Laura María Belluscio; Bruno Gabriel Berardino; Daniela Susana Castillo; Eduardo Tomás Cánepa
Journal:  Mol Cell Biochem       Date:  2016-11-05       Impact factor: 3.396

3.  A novel, ataxic mouse model of ataxia telangiectasia caused by a clinically relevant nonsense mutation.

Authors:  Harvey Perez; May F Abdallah; Jose I Chavira; Angelina S Norris; Martin T Egeland; Karen L Vo; Callan L Buechsenschuetz; Valentina Sanghez; Jeannie L Kim; Molly Pind; Kotoka Nakamura; Geoffrey G Hicks; Richard A Gatti; Joaquin Madrenas; Michelina Iacovino; Peter J McKinnon; Paul J Mathews
Journal:  Elife       Date:  2021-11-01       Impact factor: 8.713

4.  Prognostic Significance of Nuclear Phospho-ATM Expression in Melanoma.

Authors:  Madhuri Bhandaru; Magdalena Martinka; Kevin J McElwee; Anand Rotte
Journal:  PLoS One       Date:  2015-08-14       Impact factor: 3.240

5.  miR-30a radiosensitizes non-small cell lung cancer by targeting ATF1 that is involved in the phosphorylation of ATM.

Authors:  Yuyan Guo; Wenze Sun; Tuotuo Gong; Yanlan Chai; Juan Wang; Beina Hui; Yi Li; Liping Song; Ying Gao
Journal:  Oncol Rep       Date:  2017-02-14       Impact factor: 3.906

6.  Cellular and cell-free studies of catalytic DNA cleavage by ruthenium polypyridyl complexes containing redox-active intercalating ligands.

Authors:  Cynthia Griffith; Adam S Dayoub; Thamara Jaranatne; Nagham Alatrash; Ali Mohamedi; Kenneth Abayan; Zachary S Breitbach; Daniel W Armstrong; Frederick M MacDonnell
Journal:  Chem Sci       Date:  2017-03-08       Impact factor: 9.825

7.  B-Myb Induces APOBEC3B Expression Leading to Somatic Mutation in Multiple Cancers.

Authors:  Wen-Cheng Chou; Wei-Ting Chen; Chia-Ni Hsiung; Ling-Yueh Hu; Jyh-Cherng Yu; Huan-Ming Hsu; Chen-Yang Shen
Journal:  Sci Rep       Date:  2017-03-09       Impact factor: 4.379

8.  Ataxia-Telangiectasia Mutated (ATM) Protein Signaling Participates in Development of Pulmonary Arterial Hypertension in Rats.

Authors:  Fan Hu; Caijun Liu; Hanmin Liu; Liang Xie; Li Yu
Journal:  Med Sci Monit       Date:  2017-09-12

9.  A novel M phase blocker, DCZ3301 enhances the sensitivity of bortezomib in resistant multiple myeloma through DNA damage and mitotic catastrophe.

Authors:  Liangning Hu; Bo Li; Gege Chen; Dongliang Song; Zhijian Xu; Lu Gao; Mengyu Xi; Jinfeng Zhou; Liping Li; Hui Zhang; Qilin Feng; Yingcong Wang; Kang Lu; Yumeng Lu; Wenxuan Bu; Houcai Wang; Xiaosong Wu; Weiliang Zhu; Jumei Shi
Journal:  J Exp Clin Cancer Res       Date:  2020-06-09

10.  Modulation of proteostasis counteracts oxidative stress and affects DNA base excision repair capacity in ATM-deficient cells.

Authors:  Mattia Poletto; Di Yang; Sally C Fletcher; Iolanda Vendrell; Roman Fischer; Arnaud J Legrand; Grigory L Dianov
Journal:  Nucleic Acids Res       Date:  2017-09-29       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.